D-penicillamine therapy of neonatal hyperbilirubinaemia.
D000017:ABO Blood-Group System; D000284:Administration, Oral; D001663:Bilirubin / Q000097:blood; D001724:Birth Weight; D002614:Chelating Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004361:Drug Tolerance; D005078:Exchange Transfusion, Whole Blood; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007567:Jaundice, Neonatal / Q000188:drug therapy* / Q000628:therapy; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use*; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D002614:Chelating Agents; D012204:Rh-Hr Blood-Group System; D010396:Penicillamine; D001663:Bilirubin